europe

Several toad, newt, and salamander populations are being hit hard by an emerging pathogen in a pristine national park in Spain.

DNA analysis points to a third progenitor group for modern Europeans.

The pharmaceutical industry has agreed to share data from clinical trials with researchers, patients, and the public.

Asymmetry in the Research Excellence Framework in the U.K. is a threat to basic medical sciences within British medical schools.

The regulatory body that licenses drugs for use in the European Union is devising a policy that will require the publication of some clinical trial data.

After decades of political wrangling, the European Union is poised to introduce a single patent system to reduce red tape and application costs for researchers and companies.

A handful of French science academies and government agencies add to a growing chorus of doubts that genetically modified corn causes tumors and early death in rats.

The European Food Safety Authority is unconvinced by a study linking genetically modified crops to cancer and early death.

A powerful consortium of research organizations in Europe speaks out against a recent ruling to ban patenting of research on human embryonic stem cells.

In the midst of the continent’s economic troubles, the European Commission is pushing for a big rise in science funding.